Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE DE MAUPAS : revenue, balance sheet and financial ratios

PHARMACIE DE MAUPAS is a French company founded 9 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in SOISSONS (02200), this company of category PME shows in 2025 a net income positive of 159 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Historique financier - PHARMACIE DE MAUPAS (SIREN 820477826)
Kennzahl 2025 2024 2023 2022 2021 2020 2019 2018 2017
Umsatz N/C N/C N/C N/C N/C N/C N/C N/C N/C
Nettoergebnis 159 036 € 100 034 € 141 102 € 143 357 € 161 997 € 122 941 € 126 174 € 105 635 € 87 864 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C N/C
Nettomarge N/C N/C N/C N/C N/C N/C N/C N/C N/C

Umsatz und Gewinn- und Verlustrechnung

In 2025, PHARMACIE DE MAUPAS generates positive net income of 159 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 88 k€ -> 159 k€.

Nettoergebnis (2025) ?
Nettoergebnis
Definition
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Formel
Ordentliches Ergebnis + Außerordentliches Ergebnis - Ertragsteuern

159 036 €

Chargement du compte de résultat...

Évolution graphique

Anzeigen :

Aktiva

Chargement des données...

Passiva

Chargement des données...

Solvenz- und Verschuldungskennzahlen

The debt ratio (= Financial debt / Equity x 100) stands at 30%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 65%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Verschuldungsgrad (2025) ?
Verschuldungsgrad
Definition
Misst das Verhältnis von Schulden zu Eigenkapital.
Formel
(Finanzschulden / Eigenkapital) x 100
Interpretation
< 50% : Faible
50-100% : Moderat
> 100% : Hoch

30.088%

Finanzielle Autonomie (2025) ?
Finanzielle Autonomie
Definition
Anteil des Eigenkapitals an der Gesamtfinanzierung.
Formel
(Eigenkapital / Bilanzsumme) x 100
Interpretation
> 30% : Gute Autonomie
20-30% : Durchschnitt
< 20% : Faible

65.309%

Anlagenaltersquote (2025) ?
Anlagenaltersquote
Definition
Misst den Abnutzungsgrad des Sachanlagevermögens.
Formel
Kumulierte Abschreibungen / Bruttoanlagevermögen x 100
Interpretation
< 50% : Neue Anlagen
50-70% : Normale Abnutzung
> 70% : Alternde Anlagen

15.7%

Entwicklung der Solvenzkennzahlen
PHARMACIE DE MAUPAS

Positionnement sectoriel

Debt ratio
30.09 2025
2023
2024
2025
Q1: 13.57
Méd: 49.47
Q3: 128.28
Good -10 pts über 3 Jahre

In 2025, the debt ratio of PHARMACIE DE MAUPAS (30.09) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
65.31% 2025
2023
2024
2025
Q1: 33.69%
Méd: 53.88%
Q3: 72.26%
Good +10 pts über 3 Jahre

In 2025, the financial autonomy of PHARMACIE DE MAUPAS (65.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquiditätskennzahlen

The liquidity ratio (= Current assets / Current liabilities) stands at 215.88. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquiditätsquote (2025) ?
Liquiditätsquote
Definition
Fähigkeit, kurzfristige Schulden mit dem Umlaufvermögen zu decken.
Formel
Umlaufvermögen / Kurzfristige Verbindlichkeiten
Interpretation
> 1.5 : Sehr gut
1-1.5 : Angemessen
< 1 : Risque de liquidité

215.879

Entwicklung der Liquiditätskennzahlen
PHARMACIE DE MAUPAS

Positionnement sectoriel

Liquidity ratio
215.88 2025
2023
2024
2025
Q1: 131.48
Méd: 182.6
Q3: 258.72
Good +8 pts über 3 Jahre

In 2025, the liquidity ratio of PHARMACIE DE MAUPAS (215.88) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Positionnement de PHARMACIE DE MAUPAS dans son secteur

Vergleich mit der Branche Commerce de détail de produits pharmaceutiques en magasin spécialisé

Bewertungsschätzung

Based on 277 transactions of similar company sales in 2025, the value of PHARMACIE DE MAUPAS is estimated at 2 526 305 € (range 1 714 363€ - 3 964 121€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
1714k€ 2526k€ 3964k€
2 526 305 € Range: 1 714 363€ - 3 964 121€
NAF 5 année 2025

Valuation method used

Net Income Multiple
159 036 € × 15.9x = 2 526 306 €
Range: 1 714 363€ - 3 964 122€

Only this financial indicator is available for this company.

Bewertungsentwicklung

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE DE MAUPAS with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE DE MAUPAS

What is the revenue of PHARMACIE DE MAUPAS ?

The revenue of PHARMACIE DE MAUPAS is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE DE MAUPAS profitable?

Yes, PHARMACIE DE MAUPAS generated a net profit of 159 k€ in 2025.

Where is the headquarters of PHARMACIE DE MAUPAS ?

The headquarters of PHARMACIE DE MAUPAS is located in SOISSONS (02200), in the department Aisne.

Where to find the tax return of PHARMACIE DE MAUPAS ?

The tax return of PHARMACIE DE MAUPAS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE DE MAUPAS operate?

PHARMACIE DE MAUPAS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.